Almuradova D.M., Ravshanova N.B., & Abdurakhimov A.I. (2026). Clinical Outcomes of EGFR-Targeted Therapy with Erlotinib Versus Polychemotherapy in NSCLC: A Statistical Analysis. International Journal of Medical Sciences And Clinical Research, 6(03), 82–86. https://doi.org/10.37547/ijmscr/Volume06Issue03-18